Cargando…
Assessment of carnitine excretion and its ratio to plasma free carnitine as a biomarker for primary carnitine deficiency in newborns
In the Netherlands, newborns are referred by the newborn screening (NBS) Program when a low free carnitine (C0) concentration (<5 μmol/l) is detected in their NBS dried blood spot. This leads to ~85% false positive referrals who all need an invasive, expensive and lengthy evaluation. We investiga...
Autores principales: | Crefcoeur, Loek L., Heiner‐Fokkema, M. Rebecca, Maase, Rose E., Visser, Gepke, de Sain‐van der Velden, Monique G. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830017/ https://www.ncbi.nlm.nih.gov/pubmed/36636597 http://dx.doi.org/10.1002/jmd2.12334 |
Ejemplares similares
-
Neonatal carnitine concentrations in relation to gestational age and weight
por: Crefcoeur, Loek L., et al.
Publicado: (2020) -
Clinical characteristics of primary carnitine deficiency: A structured review using a case‐by‐case approach
por: Crefcoeur, Loek L., et al.
Publicado: (2022) -
A qualitative study on the perspectives of mothers who had been diagnosed with primary carnitine deficiency through newborn screening of their child
por: van den Heuvel, Lieke M., et al.
Publicado: (2023) -
Primary carnitine deficiency is a life‐long disease
por: Crefcoeur, Loek L., et al.
Publicado: (2022) -
Acylcarnitine ratio indices in diagnosing carnitine-acylcarnitine translocase deficiency in newborns
por: Tan, Yifei, et al.
Publicado: (2023)